140 related articles for article (PubMed ID: 17437166)
1. Celecoxib prevents juxta-articular osteopenia and growth plate destruction adjacent to inflamed joints in rats with collagen-induced arthritis.
Tsuboi H; Nampei A; Matsui Y; Hashimoto J; Kawai S; Ochi T; Yoshikawa H
Mod Rheumatol; 2007; 17(2):115-22. PubMed ID: 17437166
[TBL] [Abstract][Full Text] [Related]
2. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
[TBL] [Abstract][Full Text] [Related]
3. Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats.
Noguchi M; Kimoto A; Sasamata M; Miyata K
J Bone Miner Metab; 2008; 26(5):461-8. PubMed ID: 18758904
[TBL] [Abstract][Full Text] [Related]
4. Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats.
Bendele AM; McComb J; Gould T; Frazier J; Chlipala ES; Seely J; Kieft G; Wolf J; Edwards CK
Inflamm Res; 1999 Aug; 48(8):453-60. PubMed ID: 10493163
[TBL] [Abstract][Full Text] [Related]
5. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clodronate and indomethacin in the treatment of adjuvant arthritis.
Osterman T; Kippo K; Laurén L; Pasanen I; Hannuniemi R; Sellman R
Inflamm Res; 1997 Mar; 46(3):79-85. PubMed ID: 9098719
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing.
Cohen DB; Kawamura S; Ehteshami JR; Rodeo SA
Am J Sports Med; 2006 Mar; 34(3):362-9. PubMed ID: 16210573
[TBL] [Abstract][Full Text] [Related]
8. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration.
Thakkar H; Kumar Sharma R; Murthy RS
Drugs R D; 2007; 8(5):275-85. PubMed ID: 17767393
[TBL] [Abstract][Full Text] [Related]
9. Blockade of parathyroid hormone-related protein prevents joint destruction and granuloma formation in streptococcal cell wall-induced arthritis.
Funk JL; Chen J; Downey KJ; Davee SM; Stafford G
Arthritis Rheum; 2003 Jun; 48(6):1721-31. PubMed ID: 12794841
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective COX-2 inhibitor, celecoxib on adjuvant-induced arthritis model in irradiated rats.
El-Ghazaly MA; Nada AS; El-Hazek RM; Khayyal MT
Int J Radiat Biol; 2010 Dec; 86(12):1079-87. PubMed ID: 20698743
[TBL] [Abstract][Full Text] [Related]
11. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
12. High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton.
Oelzner P; Kunze A; Henzgen S; Thoss K; Hein G; Stein G; Bräuer R
Inflamm Res; 2000 Aug; 49(8):424-33. PubMed ID: 11028760
[TBL] [Abstract][Full Text] [Related]
13. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
14. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects.
Ochi T; Goto T
J Pharm Pharmacol; 2000 May; 52(5):553-60. PubMed ID: 10864144
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice.
Sakaguchi Y; Shirahase H; Ichikawa A; Kanda M; Nozaki Y; Uehara Y
Life Sci; 2004 Sep; 75(19):2257-67. PubMed ID: 15350824
[TBL] [Abstract][Full Text] [Related]
17. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
Stolina M; Adamu S; Ominsky M; Dwyer D; Asuncion F; Geng Z; Middleton S; Brown H; Pretorius J; Schett G; Bolon B; Feige U; Zack D; Kostenuik PJ
J Bone Miner Res; 2005 Oct; 20(10):1756-65. PubMed ID: 16160733
[TBL] [Abstract][Full Text] [Related]
18. The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.
Batu OS; Erol K
Inflammopharmacology; 2007 Dec; 15(6):260-5. PubMed ID: 18236017
[TBL] [Abstract][Full Text] [Related]
19. Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin.
Roh JL; Sung MW; Kim KH
Head Neck; 2005 Apr; 27(4):326-32. PubMed ID: 15719392
[TBL] [Abstract][Full Text] [Related]
20. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
